A Comparison of Capsular Contracture Rates after Immediate Implant-based Breast Reconstruction Using Biologic versus...

Area of Science:

• Plastic Surgery
• Biomaterials Science
• Oncology

Background:

• Capsular contracture is a common complication following implant-based breast reconstruction, often necessitating reoperation.
• Previous research indicates that biologic mesh may reduce the incidence of capsular contracture.
• This study directly compares capsular contracture rates between biologic and synthetic mesh in immediate breast reconstruction.

Purpose of the Study:

• To compare the incidence of capsular contracture between patients receiving immediate implant-based breast reconstruction with biologic versus synthetic mesh.
• To identify potential risk factors associated with capsular contracture development in this patient population.

Main Methods:

• Retrospective review of primary implant-based breast reconstructions from 2008 to 2023.
• Comparison of demographics and Baker grade III or IV capsular contracture rates between biologic and synthetic mesh cohorts.
• Univariate and multivariate logistic regression analyses to assess risk factors for capsular contracture.

Main Results:

• A total of 772 breasts were analyzed: 689 (89.2%) with biologic mesh and 83 (10.8%) with synthetic mesh.
• Capsular contracture occurred in 2.2% of biologic mesh cases and 3.6% of synthetic mesh cases (P=0.430), showing no significant difference.
• Radiation emerged as a borderline significant risk factor, while mesh type (biologic vs. synthetic) was not significant (P=0.351).

Conclusions:

• Both biologic and synthetic meshes are effective in prosthetic breast reconstruction with low rates of capsular contracture.
• Current long-term data suggest no significant difference in capsular contracture risk between biologic and synthetic mesh materials.
• A re-evaluation of how capsular contracture is assessed and discussed in breast reconstruction is warranted.